Project Grant R01CA286648
Award Date
8/1/24
Completion Date
7/31/28
Dollars Obligated
$1.3M
Federal Agency
National Cancer Institute
Federal Grant Program
93.394
Assistance Type
Project Grant
Place of Performance
Houston, TX 77204, USA
Similar Awards
This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) provides $155,028 to Georgia Tech Research Corp to develop an advanced 3D auxetic biodegradable implant for large volume breast reconstruction. The research aims to address limitations of current breast reconstruction approaches by scaling up a novel auxetic architecture design to enhance flexibility, durability, permeability, and tissue regeneration capabilities. Key objectives...
This federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), aims to develop an x-ray dual-energy cone-beam microCT (DECB microCT) system for intraoperative imaging of lumpectomy specimens during breast-conserving surgery (BCS). The $2,020,098 award to the University of Chicago will support the following key objectives over the 5-year project period: Develop the DECB microCT technology to provide enhanced...
The National Cancer Institute (NCI) awarded a $549,536 Project Grant (CFDA 93.394 - Cancer Detection and Diagnosis Research) to Trustees of Dartmouth College to develop a comprehensive 3D wearable near-infrared (NIR) spectral tomography system for early prediction of residual cancer burden in breast cancer patients undergoing neoadjuvant chemotherapy. The project aims to integrate flexible circuit strips into a sleek, 64-channel wearable breast interface and apply 3D image reconstruction...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), aims to evaluate the performance of four commercial mammography-based artificial intelligence (AI) algorithms for breast cancer risk prediction in a diverse U.S. screening population. The $989,122 award to the University of Washington will be used to assess the accuracy and performance of these AI-based risk models across different race and ethnicity groups,...
The National Cancer Institute (NCI) awarded a $505,613 Project Grant (CFDA 93.394 - Cancer Detection and Diagnosis Research) to the Fred Hutchinson Cancer Center in Seattle, WA. The grant, awarded on December 4, 2024, supports the development of statistical and computational approaches to leverage genomic data and spatial omics technology for precision cancer prevention. The key objectives are to: 1) Create deep learning-based methods to identify tumor subtypes associated with poor outcomes...
The National Cancer Institute awarded a $450,000 Project Grant under the Cancer Biology Research (CFDA 93.396) federal grant program to The Research Foundation For The State University Of New York, doing business as Stony Brook University. The grant, spanning August 2024 to July 2028, aims to develop advanced topological data analysis (TDA) techniques for extracting and interpreting fine-grained structural information from breast imaging. The project, called TOPOQUANT, will create new TDA...
This $247,660 federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) supports research at Weill Medical College of Cornell University to characterize the effects of different intraoperative fat grafting processing techniques on the microenvironment and retention of autologous fat grafts. The researchers will compare volume retention and cellular characteristics of fat grafts processed using three different techniques - active closed wash and...
This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) provides $1,312,317 to The Johns Hopkins University to develop engineered biomimetic cancer invasion models for screening chemotherapeutic agents. The goal is to identify drugs that effectively inhibit breast cancer metastasis, which is a major cause of cancer mortality. The award supports the creation of quasi-3D nanotopographically patterned substrates and 3D aligned collagen...
This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) totaling $692,248 will support the development of novel analytic methods and computational tools for diagnosing and characterizing aggressive forms of cancer, particularly prostate cancer. The key objectives are to establish an analytic framework and methodology for "disease ruling" - accurately ruling out or ruling in the presence of aggressive cancer - through the use...
The National Cancer Institute (NCI) awarded a $164,639 Project Grant under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to Brown University. The research project aims to employ quantitative image analysis based on deep learning to improve treatment efficacy in image-guided renal tumor ablation. Specifically, the project seeks to develop a novel fully automated pipeline for kidney segmentation and registration using deep learning techniques. This is expected to reduce the...